Intrinsic Value

BWVI latest financial reports are more than 10 years old.
BWVI doesn't have a meaningful market cap.
Not Available for BWVI

There is not enough data to reliably calculate the intrinsic value for Psycheceutical Bioscience Inc.

Do our valuations actually work? See backtest results .

Alternatives to BWVI

Fundamental Analysis

What Psycheceutical Bioscience Does

Psycheceutical Bioscience, Inc. engages in psychedelic medicine and represents the potential for major progress in the area of mental health treatment. The company is headquartered in Fleming Island, Florida and currently employs 28 full-time employees. The company went IPO on 2007-05-25. The Company’s patented NeuroDirect non-systemic delivery technology is designed to deliver neuro-active compounds directly into the nerve tissue via topical application at the back of the neck.

Headquarters
United States of America US
Employees
28
IPO date
May 25, 2007
Read the full company overview
View Company Overview
Financials
Efficiency

Earnings Waterfall
Psycheceutical Bioscience Inc

Wall St Price Targets

Capital Returns

Buyback Yield
LOCKED
Debt Paydown Yield
LOCKED

Competitive Landscape